TVAX Biomedical, Inc. – Product Pipeline Review

Global Markets Direct’s, ‘TVAX Biomedical, Inc. – Product Pipeline Review – 2016’, provides an overview of the TVAX Biomedical, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by TVAX Biomedical, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of TVAX Biomedical, Inc.

The report provides overview of TVAX Biomedical, Inc. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses TVAX Biomedical, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features TVAX Biomedical, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate TVAX Biomedical, Inc.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for TVAX Biomedical, Inc.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding TVAX Biomedical, Inc.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

TVAX Biomedical, Inc. Snapshot 5

TVAX Biomedical, Inc. Overview 5

Key Information 5

Key Facts 5

TVAX Biomedical, Inc. - Research and Development Overview 6

Key Therapeutic Areas 6

TVAX Biomedical, Inc. - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

TVAX Biomedical, Inc. - Pipeline Products Glance 10

TVAX Biomedical, Inc. - Clinical Stage Pipeline Products 10

Phase II Products/Combination Treatment Modalities 10

Phase I Products/Combination Treatment Modalities 11

TVAX Biomedical, Inc. - Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

TVAX Biomedical, Inc. - Drug Profiles 13

TVI-Brain-1 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

TVI-Kidney-1 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

TVI-Breast-1 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

TVI-Colon-1 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

TVI-Leukemia-1 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

TVI-Lung-1 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

TVI-Melanoma-1 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

TVI-Ovary-1 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

TVI-Pancreas-1 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

TVI-Prostate-1 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

TVI-Hepatitis-1 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

TVI-HIV-1 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

TVI-Tuberculosis-1 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

TVAX Biomedical, Inc. - Pipeline Analysis 27

TVAX Biomedical, Inc. - Pipeline Products by Route of Administration 27

TVAX Biomedical, Inc. - Pipeline Products by Molecule Type 28

TVAX Biomedical, Inc. - Recent Pipeline Updates 29

TVAX Biomedical, Inc. - Locations And Subsidiaries 30

Head Office 30

Appendix 31

Methodology 31

Coverage 31

Secondary Research 31

Primary Research 31

Expert Panel Validation 31

Contact Us 31

Disclaimer 32

List of Tables

List of Tables

TVAX Biomedical, Inc., Key Information 5

TVAX Biomedical, Inc., Key Facts 5

TVAX Biomedical, Inc. – Pipeline by Indication, 2016 7

TVAX Biomedical, Inc. – Pipeline by Stage of Development, 2016 8

TVAX Biomedical, Inc. – Monotherapy Products in Pipeline, 2016 9

TVAX Biomedical, Inc. – Phase II, 2016 10

TVAX Biomedical, Inc. – Phase I, 2016 11

TVAX Biomedical, Inc. – Preclinical, 2016 12

TVAX Biomedical, Inc. – Pipeline by Route of Administration, 2016 27

TVAX Biomedical, Inc. – Pipeline by Molecule Type, 2016 28

TVAX Biomedical, Inc. – Recent Pipeline Updates, 2016 29

List of Figures

List of Figures

TVAX Biomedical, Inc. – Pipeline by Top 10 Indication, 2016 7

TVAX Biomedical, Inc. – Pipeline by Stage of Development, 2016 8

TVAX Biomedical, Inc. – Monotherapy Products in Pipeline, 2016 9

TVAX Biomedical, Inc. – Pipeline by Route of Administration, 2016 27

TVAX Biomedical, Inc. – Pipeline by Molecule Type, 2016 28

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports